Biostar Pharmaceuticals
Open
–
Prev. Close
–
High
–
Low
–
Market Snapshot
$2.66
0.0
-0.10
200
BioStar Pharmaceuticals, Inc. engages in the development, manufacture, and marketing of pharmaceutical and health supplement products for a variety of diseases and conditions. The company is headquartered in Xianyang, Shaanxi. The company went IPO on 2008-07-09. The Company, through its subsidiary, Shaanxi Biostar Biotech, Ltd. (Shaanxi Biostar), and its variable interest entities (VIEs), Shaanxi Aoxing Pharmaceutical Co., Ltd. (Aoxing Pharmaceutical) and Shaanxi Weinan Huaren Pharmaceuticals Ltd. (Shaanxi Weinan), develops, manufactures and markets pharmaceutical products for various diseases and conditions in the People's Republic of China (PRC or China). The firm offers over-the-counter (OTC) products and prescription-based pharmaceuticals. The firm's products include XinAoxing Oleanolic Acid Capsule, Ganwang Compound Paracetamol Capsule, Tianqi Dysmenorrhea Capsule, Compound Paracetamol and Amantadine Hydrochloride Tablets, Deafness Tongqiao pills and Huangyangning Tablets.
emptyResult
BioStar Pharmaceuticals, Inc. engages in the development, manufacture, and marketing of pharmaceutical and health supplement products for a variety of diseases and conditions. The company is headquartered in Xianyang, Shaanxi. The company went IPO on 2008-07-09. The Company, through its subsidiary, Shaanxi Biostar Biotech, Ltd. (Shaanxi Biostar), and its variable interest entities (VIEs), Shaanxi Aoxing Pharmaceutical Co., Ltd. (Aoxing Pharmaceutical) and Shaanxi Weinan Huaren Pharmaceuticals Ltd. (Shaanxi Weinan), develops, manufactures and markets pharmaceutical products for various diseases and conditions in the People's Republic of China (PRC or China). The firm offers over-the-counter (OTC) products and prescription-based pharmaceuticals. The firm's products include XinAoxing Oleanolic Acid Capsule, Ganwang Compound Paracetamol Capsule, Tianqi Dysmenorrhea Capsule, Compound Paracetamol and Amantadine Hydrochloride Tablets, Deafness Tongqiao pills and Huangyangning Tablets.
Recently from Cashu
Biostar Pharmaceuticals Launches Clinical Study for Utidelone Injection in Brain Metastatic Breast Cancer
Biostar Pharmaceuticals Advances Cancer Treatment with Utidelone Injection Clinical Study Biostar Pharmaceuticals, Inc., a U.S. subsidiary of Beijing Biostar Pharmaceuticals Co., Ltd., commences a piv…
Biostar Pharmaceuticals Secures FDA Orphan Drug Designation for Pancreatic Cancer Treatment Utidelone
Biostar Pharmaceuticals Gains FDA Orphan Drug Designation for Utidelone in Pancreatic Cancer Treatment Biostar Pharmaceuticals, a subsidiary of Beijing Biostar Biopharmaceutical Co., Ltd., secures Orp…
Biostar Pharmaceuticals Forms Strategic Alliance with Novotech to Boost Oncology Development
Strategic Alliance Enhances Oncology Development for Biostar Pharmaceuticals Beijing Biostar Pharmaceuticals Co., Ltd. enters a significant phase in its growth trajectory with a long-term strategic pa…
Biostar Pharmaceuticals Partners with Novotech to Enhance Oncology Drug Development and Innovation
Strategic Partnership to Propel Oncology Innovation In a significant move to enhance its clinical research capabilities, Beijing Biostar Pharmaceuticals Co., Ltd. has entered into a long-term strategi…